MODERN POSSIBILITIES OF THERAPY OF TYPE 2 DIABETES MELLITUS PATIENTS. EFFECTIVENESS AND CARDIOSAFETY OF ALOGLIPTIN FROM THE POINT OF VIEW OF EVIDENCE-BASED MEDICINE
According to the IDF (2016) 1 of 11 adult patients suffers from diabetes mellitus (DM). The total number of diabetic patients is 415 million. By 2040, according to analysts of the International Diabetes Federation, the number of the sick increases and the disease will affect 1 in 10 people. It is ex...
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | Russian |
| Baskı/Yayın Bilgisi: |
Remedium Group LLC
2017-07-01
|
| Seri Bilgileri: | Медицинский совет |
| Konular: | |
| Online Erişim: | https://www.med-sovet.pro/jour/article/view/1933 |